UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056790 |
|---|---|
| Receipt number | R000064883 |
| Scientific Title | CONNECT-Oncology Project: COnsultation system of Nationwide medical NEeds with onlineCommunication Tool in Oncology |
| Date of disclosure of the study information | 2025/01/23 |
| Last modified on | 2025/01/23 06:37:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
CONNECT-Oncology Project: COnsultation system of Nationwide medical NEeds with onlineCommunication Tool in Oncology
Acronym
CONNECT-Oncology
Scientific Title
CONNECT-Oncology Project: COnsultation system of Nationwide medical NEeds with onlineCommunication Tool in Oncology
Scientific Title:Acronym
CONNECT-Oncology
Region
| Japan |
Condition
Condition
Solid and hematologic tumors are included in the eligibility criteria.
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
The development of novel cancer therapies has increasingly complicated cancerpharmacotherapy. For regional medical institutions to provide optimal cancer care, more specialized medical knowledge and experience are requiredthan ever before. To ensure the delivery of optimal cancer care, it is crucial to establish a system that enables physicians at regional medicalinstitutions to consult directly with physicians at cancer-specialized hospitals who possess extensive expertise and experience in cancer treatment. This study aims to evaluate the implementation of an online consultation system that facilitates direct discussions between physicians at cancer-specialized hospitals and regional medical institutions regarding cancer treatment.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To confirm the feasibility of system construction and operation and the usefulness of consultation at each medical institution using this system, targeting those responses that provide sufficient information in the questionnaire (more than 50% of the responses were filled out).To evaluate various items related to the feasibility of establishing and operating an online consultation system at the National Cancer Center Hospital.
Key secondary outcomes
Concordance rate of treatment strategies and clinical guidelinesadherence, leading to improved prognosis.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | < |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Health care professionals (target age: adult) who belong to the collaboratingmedicalinstitutions participating in this study and who are involved in cancer treatment will be included in the study.
Key exclusion criteria
All participants in this study are adults.
Target sample size
170
Research contact person
Name of lead principal investigator
| 1st name | Kan |
| Middle name | |
| Last name | Yonemori |
Organization
National Cancer Center Hospital
Division name
Department of Medical Oncology
Zip code
1040045
Address
5-1-1 Tsukiji Chuo-ku Tokyo
TEL
03-3542-2511
kyonemor@ncc.go.jp
Public contact
Name of contact person
| 1st name | Tatsunori |
| Middle name | |
| Last name | Shimoi |
Organization
National Cancer Center Hospital
Division name
Department of Medical Oncology
Zip code
104-0045
Address
5-1-1 Tsukiji Chuo-ku Tokyo
TEL
03-3542-2511
Homepage URL
tshimoi@ncc.go.jp
Sponsor or person
Institute
National Cancer Center Hospital
Institute
Department
Personal name
Funding Source
Organization
Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Allm Inc.
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Cancer Center Hospital
Address
5-1-1 Tsukiji Chuo-ku Tokyo
Tel
03-3542-2511
ncch-irb@ml.res.ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 01 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2023 | Year | 05 | Month | 29 | Day |
Date of IRB
| 2023 | Year | 07 | Month | 25 | Day |
Anticipated trial start date
| 2023 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Change in treatment and effectiveness
Outcome of consultationSatisfaction Assessment
Evaluation of system operation
Economic evaluation, etc.
Management information
Registered date
| 2025 | Year | 01 | Month | 23 | Day |
Last modified on
| 2025 | Year | 01 | Month | 23 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064883
